Cryospray to Reduce Pain During Venous Cannulation

Sponsor
University of Southern Denmark (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04865783
Collaborator
(none)
130
1
2
13.2
9.8

Study Details

Study Description

Brief Summary

This trial aims to evaluate if cryospray can reduce pain during intravenous cannulation in elective surgery compared to a placebo spray.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Saline spray
  • Procedure: Cryospray
N/A

Detailed Description

Venous cannulation is a common practice in the health care system. Before any procedure, intravenous access is always placed before induction of any anaesthesia. For many patients placement of a venous catheter is associated with pain and discomfort. Any quick and easy reduction in pain during the procedure is important for patients. Cryospray has been described as an easy-to-use supplement of analgesia to alleviate pain during intravenous access. Cryospray has been shown to reduce pain in venous cannulation in the emergency setting but not in the elective setting. A search in the literature reveals 2 recent metanalyses reporting 8 included trials and 11 included trials, respectively. Both metanalyses call for further research in relation to patients' satisfaction. By randomizing patients to either cryospray or placebo before venous cannulation, we hypothesize that cryospray reduces pain during venous cannulation compared to placebo.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
130 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Masking Description:
Before elective surgery, all patients will have an intravenous line placed before induction of anaesthesia. Patients will be blinded to whether cryospray or placebo is used. Two anaesthesia trained persons (nurse/doctors) will perform the procedure. One person will randomize and apply the randomized spray and the other person will be blinded to the randomized treatment. The anesthesiologist performing the puncture but blinded for randomization will fill out a questionnaire
Primary Purpose:
Treatment
Official Title:
Cryospray to Reduce Pain During Venous Cannulation - Randomized Placebo-controlled Study
Actual Study Start Date :
May 25, 2021
Anticipated Primary Completion Date :
Jul 1, 2022
Anticipated Study Completion Date :
Jul 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Cryospray

Cryospray will be sprayed from a distance of 20-30 cm to the back of one hand.

Procedure: Cryospray
The cryospray will be applied twice for 1-2 seconds.

Placebo Comparator: Placebo

A saline solution will be sprayed from a distance of 20-30 cm to the back of the hand.

Procedure: Saline spray
The saline spray will be applied twice for 1-2 seconds.

Outcome Measures

Primary Outcome Measures

  1. Patients reported pain from the puncture site [immediately after completion of vein canulation]

    After vein puncture is completed patients is asked on a scale from 0-10 to indicate pain during vein canulation (zero no pain, 10 worst possible pain)

Secondary Outcome Measures

  1. Difficulty in placement of intravenous line [immediately after completion of vein canulation]

    After vein puncture is completed the operator is asked to the difficulty in placement of the venous line (0-10, zero very easy and ten very difficult).

  2. Number of successful placements of venous line at first attempt [immediately after completion of vein canulation]

    After vein puncture is completed it is indicated wether or not it was successful in first attempt.

Other Outcome Measures

  1. Discomfort from puncture site at discharge from recovery [up to 24 hours after discharge from recovery room]

    After discharge from the recovery room patients is asked for any discomfort at the puncture site. If yes: pain, numbness, burning or cold feeling. All positive values rated on the numeric rating scale (0-10).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 years or older and able to give consent
Exclusion Criteria:
  • Unable to give consent

  • Infection

  • coloring or bruises at the puncture site (use of corticosteroid etc).

  • No vein signs visible after application of vein stasis.

  • Allergy to coolant spray.

  • Contraindication for vein stasis or vein cannulation (ex Raynauds disease etc).

  • Has participated earlier in the trial.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sygehus Soenderjylland Aabenraa Denmark 6200

Sponsors and Collaborators

  • University of Southern Denmark

Investigators

  • Principal Investigator: Thomas Strøm, University Hospital of Southern Denmark

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University of Southern Denmark
ClinicalTrials.gov Identifier:
NCT04865783
Other Study ID Numbers:
  • SHS-BI-4a-2021
First Posted:
Apr 29, 2021
Last Update Posted:
Nov 30, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Southern Denmark

Study Results

No Results Posted as of Nov 30, 2021